I. Paul Bae
Keine laufenden Positionen mehr
Profil
I.
Paul Bae worked as Litigation Director at Alpha Therapeutic Corp., Vice President-Human Resources at Aerie Pharmaceuticals, Inc., and VP-Global Human Resources at St. Jude Medical LLC.
He completed his undergraduate degree at the University of California, Los Angeles and his graduate degree at Mcgeorge School of Law.
Ehemalige bekannte Positionen von I. Paul Bae
| Unternehmen | Position | Ende |
|---|---|---|
Alpha Therapeutic Corp.
 Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | General Counsel | - |
| AERIE PHARMACEUTICALS, INC. | Personalreferent | - |
| ST JUDE MEDICAL INC | Verwaltungsdirektor | - |
Ausbildung von I. Paul Bae
| University of California, Los Angeles | Undergraduate Degree |
| Mcgeorge School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
